Bonafede, Machaon <br/><br/>
Etanercept-Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis.  [electronic resource] 

 -  Arthritis care & research  Dec 2015 
 - 1656-63 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2151-4658 
<br/><br/><label>Standard No.: </label>10.1002/acr.22638  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antirheumatic Agents--adverse effects<br/>Arthritis, Rheumatoid--diagnosis<br/>Databases, Factual<br/>Drug Therapy, Combination<br/>Etanercept--adverse effects<br/>Female<br/>Humans<br/>Hydroxychloroquine--adverse effects<br/>Logistic Models<br/>Male<br/>Medicare Part B<br/>Medication Adherence<br/>Methotrexate--adverse effects<br/>Middle Aged<br/>Multivariate Analysis<br/>Odds Ratio<br/>Retrospective Studies<br/>Sulfasalazine--adverse effects<br/>Time Factors<br/>Treatment Outcome<br/>United States<br/>Young Adult